未登录

何

何立儒 (Li-Ru He)

sun yatsen university

H指数:14

被引数:691

个人简介

"2007.6获得中山大学肿瘤学硕士学位（临床医学七年制）；2016.6获得中山大学肿瘤学博士学位。2007.7入职中山大学肿瘤防治中心放疗科，2010.6完成肿瘤学专科医师培训；2010.12获聘主治医师；2011年入选中山大学肿瘤防治中心优才计划培养对象；2013年以国家公派身份到美国M.D.Anderson癌症中心进修1年；2015.4加入我院泌尿肿瘤MDT团队，负责泌尿系统肿瘤放疗；2015.12晋升副主任医师；2020.9获聘放疗科主诊教授；2020.12晋升主任医师。"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer

CELL DEATH & DISEASE

IF9.6

2019-02-0445

OAAI

Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma

SCIENTIFIC REPORTS

IF3.9

2015-12-1617

OAAI

Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2015-08-015

PREAI

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma

IF3.4

2015-03-0912

OAAI

Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone

RADIATION ONCOLOGY

IF3.2

2014-11-265

OAAI

The Modified Glasgow Prognostic Score Is an Independent Prognostic Factor in Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy

JOURNAL OF CANCER

IF3.2

2014-01-0141

OAAI

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway

MOLECULAR CANCER

IF33.9

2013-11-2340

OAAI

β-Catenin/POU5F1/SOX2 Transcription Factor Complex Mediates IGF-I Receptor Signaling and Predicts Poor Prognosis in Lung Adenocarcinoma

CANCER RESEARCH

IF16.6

2013-05-1291

OAAI

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3

尼妥珠单抗通过上调IGFBP-3促进EGFR过表达食管鳞癌细胞的放射敏感性

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2012-12-1148

OAAI

Tyrosine-Protein Phosphatase Nonreceptor Type 12 Is a Novel Prognostic Biomarker for Esophageal Squamous Cell Carcinoma

ANNALS OF THORACIC SURGERY

IF3.9

2012-05-0132

OAAI

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients

IF2.9

2010-07-28157

PREAI

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma

IF3.4

2010-04-0856

OAAI

Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma

IF3.4

2009-12-2254

OAAI